CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Grant or award President and CEO acquired 111,000 shares (grant or award)
- 4 Open-market sale Chief Technology Officer sold 2,627 shares at $26.24 ($68,925)
- 4 Exercise or conversion EVP, Research & CSO acquired 9,000 shares (option exercise)
- 4 Grant or award Chief Business Officer, Global acquired 90,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Technology Officer acquired 53,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 67,000 shares (grant or award)
- 4 Grant or award Chief Administrative Officer acquired 20,000 shares (grant or award)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $30.00 ($41,250)
- 4 Grant or award CFO acquired 35,000 shares (grant or award)
- 4 Open-market sale EVP, Research & CSO sold 2,293 shares at $31.93 ($73,218)
- 4 Open-market sale President and CEO sold 27,750 shares at an average $31.11 ($863,378)
- 4 Open-market sale Chief Administrative Officer sold 1,942 shares at $31.93 ($62,010)
- 4 Open-market sale CFO sold 2,393 shares at $31.93 ($76,411)
- 4 Open-market sale Chief Medical Officer sold 8,009 shares at an average $31.69 ($253,780)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $33.94 ($46,668)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at $34.52 ($172,620)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $32.46 ($44,633)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $35.06 ($175,304)
Page 13 of 25 · 491 filings